logo

For the Inventor, By the Inventor

Tokyo, Japan

Kimitomo Yoshioka

This inventor holds 9 USPTO granted patents and 1 EPO patent. Top assignee: Zenyaku Kogyo Kabushiki Kaisha. Active years: 1985-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimitomo Yoshioka. Retrieved from https://idiyas.com/inventor/kimitomo-yoshioka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 88.9


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Kiyose, JP (1995 - 1996)
  • Tokyo, JP (1985 - 2012)

Company Filing History:

goldMedal9 out of 41 
 
Zenyaku Kogyo Kabushiki Kaisha
 patents

Years Active: 1985-2012

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 8338414 - Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient (2012-12-25),
2. 7750001 - Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient (2010-07-06),
3. 5574033 - Heterocyclic compound and cardiotonic agent containing the same as (1996-11-12),
4. 5446042 - Heterocyclic compound and cardiotonic agent containing the same as (1995-08-29),
5. 4804668 - Thiazole derivatives and medical compositions thereof (1989-02-14),
6. 4800201 - 1,4-thiazine derivative, and cardiotonic agent comprising it as (1989-01-24),
7. 4565813 - 1,4-Thiazine derivatives (1986-01-21),
8. 4528188 - Polysaccharide PS-A obtained from barrenwort deriving from plants (1985-07-09),
9. 4501736 - Extract from barrenwort (1985-02-26),

Title: Kimitomo Yoshioka: Innovator in Immunosuppressive Agents

Introduction

Kimitomo Yoshioka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunology, particularly in the development of novel immunosuppressive agents. With a total of 9 patents to his name, Yoshioka's work is recognized for its potential impact on treating immune diseases.

Latest Patents

Yoshioka's latest patents include innovative methods for creating immunosuppressive and anti-tumor agents that utilize heterocyclic compounds as active ingredients. One of his notable inventions describes a method for administering a therapeutically effective amount of a heterocyclic compound to mammals suffering from immune diseases. This method is detailed in his patent, which outlines the general formula for the compounds involved. Additionally, he has disclosed a novel heterocyclic compound represented by a specific formula, further expanding the possibilities for pharmaceutical applications.

Career Highlights

Kimitomo Yoshioka is associated with Zenyaku Kogyo Kabushiki Kaisha, where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, particularly for its innovative approaches to treating complex health issues related to the immune system.

Collaborations

Yoshioka collaborates with esteemed colleagues such as Hiroaki Yamazaki and Muneaki Takase. Their combined expertise contributes to the advancement of research in immunosuppressive therapies and enhances the potential for groundbreaking discoveries in the field.

Conclusion

Kimitomo Yoshioka's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the development of new therapeutic agents. His work continues to pave the way for advancements in treating immune diseases, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…